Olanzapine Neuraxpharm 15 mg
As listed in the register: Olanzapine Neuraxpharm 15 mg, filmomhulde tabletten
15 mg · filmomhulde tablet
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Olanzapine
- Made by
- neuraxpharm Arzneimittel GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Olanzapine). It describes the substance, not this exact product.
The mechanism of action of olanzapine, in the listed indications is unclear.
However, the efficacy of olanzapine in schizophrenia could be mediated through a combination of dopamine and serotonin type 2 (5HT 2 ) antagonism.
It is eliminated extensively by first pass metabolism, with approximately 40% of the dose metabolized before reaching the systemic circulation.
Specific Populations Renal Impairment — Because olanzapine is highly metabolized before excretion and only 7% of the drug is excreted unchanged, renal dysfunction alone is unlikely to have a major impact on the pharmacokinetics of olanzapine.
Food does not affect the rate or extent of olanzapine absorption.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-08
Safety of the active substance
From the US prescribing label for the same active substance (Olanzapine). It describes the substance, not this exact product.
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
- None with olanzapine tablets monotherapy..
- When using olanzapine and fluoxetine in combination, also refer to the Contraindications section of the package insert for Symbyax..
- For specific information about the contraindications of lithium or valproate, refer to the Contraindications section of the package inserts for these other products..
- None with olanzapine monotherapy.
Most common adverse reactions (≥5% and at least twice that for placebo) associated with: Oral Olanzapine Monotherapy: Schizophrenia (Adults) – postural hypotension, constipation, weight gain, dizziness, personality disorder, akathisia.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States34 matching products
European UnionNo exact match for this strength and form
Spain22 matching products
- ZYPREXA VELOTAB 15 mg · comprimido bucodispersable3 makers
- ZALASTA 15 MG olanzapina · comprimido bucodispersable2 makers
- ARENBIL FLAS 15 mg · comprimido bucodispersable
- OLANZAPINA ALTER 15 mg · comprimido bucodispersable
- OLANZAPINA APOTEX 15 mg · comprimido bucodispersable
- OLANZAPINA AUROVITAS 15 mg · comprimido bucodispersable
- OLANZAPINA BENEL 15 mg · comprimido bucodispersable
- OLANZAPINA CODRAMOL 15 mg · comprimido bucodispersable
France2 matching products
Canada26 matching products
- OLANZAPINE 15 mg · tablet4 makers
- OLANZAPINE ODT 15 mg · tablet (orally-disintegrating)3 makers
- AG-OLANZAPINE FC 15 mg · tablet
- AG-OLANZAPINE ODT 15 mg · tablet (orally-disintegrating)
- APO-OLANZAPINE 15 mg · tablet
- APO-OLANZAPINE ODT 15 mg · tablet (orally-disintegrating)
- AURO-OLANZAPINE ODT 15 mg · tablet (orally-disintegrating)
- JAMP OLANZAPINE FC 15 mg · tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | neuraxpharm Arzneimittel GmbH |
|---|---|
| Active substance | Olanzapine |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 15 mg |
| Form | filmomhulde tablet |
| Classification | N05AH03 · Pain, sleep, mood, epilepsy and the brain |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Olanzapine Neuraxpharm 15 mg, filmomhulde tabletten |
| RVG | 103398 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.